Donate to the July 2019 Campaign for the Cure
It’s time for our annual Campaign for the Cure! During C4C, we focus on advancements and progress in the fight against cholangiocarcinoma.
Your support will help to initiate an important new awareness program designed to educate community physicians and patients about molecular testing and clinical trial treatment options.
We’re excited to share our new initiative to encourage molecular profiling for ALL cancer tumor.
Molecular profiling is a test your doctor can order to find out which mutations are present in the cells that make up your tumor. If you have a mutation that is also seen in other cancers, molecular profiling can open the door to other treatment options, including targeted therapies, immunotherapies, and access to clinical trials.
In the weeks ahead, we will introduce you to patients, researchers and clinicians that have used molecular profiling in their to fight against cholangiocarcinoma.
Join us in our efforts to improve patient education by making a gift today.
Campaign for the Cure Week #4: Hear from Dr. Bardeesy…
Genomic testing has shown that every cholangiocarcinoma patient has a distinct set of molecular mutations. In many cases, specific therapies can target these mutations, benefiting the patient. The development of personalized treatments based on genomic testing of cholangiocarcinoma represents an important step forward in the treatment of this disease.
The Cholangiocarcinoma Foundation’s Mutations Matter program will ensure that the greatest number of patients benefit from research and advances the understanding and treatment of cholangiocarcinoma.
-Dr. Nabeel Bardeesy